Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 165

1.

Patient-derived xenograft models: an emerging platform for translational cancer research.

Hidalgo M, Amant F, Biankin AV, Budinská E, Byrne AT, Caldas C, Clarke RB, de Jong S, Jonkers J, Mælandsmo GM, Roman-Roman S, Seoane J, Trusolino L, Villanueva A.

Cancer Discov. 2014 Sep;4(9):998-1013. doi: 10.1158/2159-8290.CD-14-0001. Epub 2014 Jul 15. Review.

2.

Patient-derived xenografts: A platform for accelerating translational research in prostate cancer.

Davies AH, Wang Y, Zoubeidi A.

Mol Cell Endocrinol. 2018 Feb 15;462(Pt A):17-24. doi: 10.1016/j.mce.2017.03.013. Epub 2017 Mar 15. Review.

PMID:
28315377
3.

[Application and development of patient-derived tumor xenograft model in translational medicine of tumor].

Wang Z, Zhu Z.

Zhonghua Wei Chang Wai Ke Za Zhi. 2017 May 25;20(5):596-600. Chinese.

PMID:
28534338
4.
5.

The Generation and Application of Patient-Derived Xenograft Model for Cancer Research.

Jung J, Seol HS, Chang S.

Cancer Res Treat. 2018 Jan;50(1):1-10. doi: 10.4143/crt.2017.307. Epub 2017 Sep 13. Review.

6.

Patient-Derived Bladder Cancer Xenografts.

Bernardo C, Santos LL.

Methods Mol Biol. 2018;1655:169-175. doi: 10.1007/978-1-4939-7234-0_14.

PMID:
28889386
7.

Patient-derived xenograft (PDX) models in basic and translational breast cancer research.

Dobrolecki LE, Airhart SD, Alferez DG, Aparicio S, Behbod F, Bentires-Alj M, Brisken C, Bult CJ, Cai S, Clarke RB, Dowst H, Ellis MJ, Gonzalez-Suarez E, Iggo RD, Kabos P, Li S, Lindeman GJ, Marangoni E, McCoy A, Meric-Bernstam F, Piwnica-Worms H, Poupon MF, Reis-Filho J, Sartorius CA, Scabia V, Sflomos G, Tu Y, Vaillant F, Visvader JE, Welm A, Wicha MS, Lewis MT.

Cancer Metastasis Rev. 2016 Dec;35(4):547-573. doi: 10.1007/s10555-016-9653-x. Review.

8.

Patient-derived xenografts for childhood solid tumors: a valuable tool to test new drugs and personalize treatments.

Zarzosa P, Navarro N, Giralt I, Molist C, Almazán-Moga A, Vidal I, Soriano A, Segura MF, Hladun R, Villanueva A, Gallego S, Roma J.

Clin Transl Oncol. 2017 Jan;19(1):44-50. doi: 10.1007/s12094-016-1557-2. Epub 2016 Oct 7. Review.

PMID:
27718156
9.

The future of patient-derived tumor xenografts in cancer treatment.

Sia D, Moeini A, Labgaa I, Villanueva A.

Pharmacogenomics. 2015;16(14):1671-83. doi: 10.2217/pgs.15.102. Epub 2015 Sep 24. Review.

PMID:
26402657
10.

Subrenal capsule grafting technology in human cancer modeling and translational cancer research.

Wang Y, Wang JX, Xue H, Lin D, Dong X, Gout PW, Gao X, Pang J.

Differentiation. 2016 Apr-Jun;91(4-5):15-9. doi: 10.1016/j.diff.2015.10.012. Epub 2015 Nov 4. Review.

PMID:
26547391
11.

Current Update of Patient-Derived Xenograft Model for Translational Breast Cancer Research.

Kawaguchi T, Foster BA, Young J, Takabe K.

J Mammary Gland Biol Neoplasia. 2017 Jun;22(2):131-139. doi: 10.1007/s10911-017-9378-7. Epub 2017 Apr 27. Review.

12.

Patient-derived xenografts as tools in pharmaceutical development.

Izumchenko E, Meir J, Bedi A, Wysocki PT, Hoque MO, Sidransky D.

Clin Pharmacol Ther. 2016 Jun;99(6):612-21. doi: 10.1002/cpt.354. Epub 2016 Mar 9. Review.

PMID:
26874468
13.

Capturing colorectal cancer inter-tumor heterogeneity in patient-derived xenograft (PDX) models.

Prasetyanti PR, van Hooff SR, van Herwaarden T, de Vries N, Kalloe K, Rodermond H, van Leersum R, de Jong JH, Franitza M, Nürnberg P, Todaro M, Stassi G, Medema JP.

Int J Cancer. 2019 Jan 15;144(2):366-371. doi: 10.1002/ijc.31767. Epub 2018 Oct 22.

14.

Movember GAP1 PDX project: An international collection of serially transplantable prostate cancer patient-derived xenograft (PDX) models.

Navone NM, van Weerden WM, Vessella RL, Williams ED, Wang Y, Isaacs JT, Nguyen HM, Culig Z, van der Pluijm G, Rentsch CA, Marques RB, de Ridder CMA, Bubendorf L, Thalmann GN, Brennen WN, Santer FR, Moser PL, Shepherd P, Efstathiou E, Xue H, Lin D, Buijs J, Bosse T, Collins A, Maitland N, Buzza M, Kouspou M, Achtman A, Taylor RA, Risbridger G, Corey E.

Prostate. 2018 Dec;78(16):1262-1282. doi: 10.1002/pros.23701. Epub 2018 Aug 2.

PMID:
30073676
15.

Mouse Models in Prostate Cancer Translational Research: From Xenograft to PDX.

Rea D, Del Vecchio V, Palma G, Barbieri A, Falco M, Luciano A, De Biase D, Perdonà S, Facchini G, Arra C.

Biomed Res Int. 2016;2016:9750795. doi: 10.1155/2016/9750795. Epub 2016 May 18. Review.

16.

Patient-derived xenografts from non-small cell lung cancer brain metastases are valuable translational platforms for the development of personalized targeted therapy.

Lee HW, Lee JI, Lee SJ, Cho HJ, Song HJ, Jeong DE, Seo YJ, Shin S, Joung JG, Kwon YJ, Choi YL, Park WY, Lee HM, Seol HJ, Shim YM, Joo KM, Nam DH.

Clin Cancer Res. 2015 Mar 1;21(5):1172-82. doi: 10.1158/1078-0432.CCR-14-1589. Epub 2014 Dec 30.

17.

Ovarian and cervical cancer patient derived xenografts: The past, present, and future.

Boone JD, Dobbin ZC, Straughn JM Jr, Buchsbaum DJ.

Gynecol Oncol. 2015 Aug;138(2):486-91. doi: 10.1016/j.ygyno.2015.05.022. Epub 2015 May 27. Review.

PMID:
26026736
18.

Patient-derived xenograft models in musculoskeletal malignancies.

Lu W, Chao T, Ruiqi C, Juan S, Zhihong L.

J Transl Med. 2018 Apr 23;16(1):107. doi: 10.1186/s12967-018-1487-6. Review.

19.

Development and Applications of Patient-Derived Xenograft Models in Humanized Mice for Oncology and Immune-Oncology Drug Discovery.

Verma B, Ritchie M, Mancini M.

Curr Protoc Pharmacol. 2017 Sep 11;78:14.41.1-14.41.12. doi: 10.1002/cpph.26.

PMID:
28892144
20.

Patient-Derived Xenograft Models for Endometrial Cancer Research.

Moiola CP, Lopez-Gil C, Cabrera S, Garcia A, Van Nyen T, Annibali D, Fonnes T, Vidal A, Villanueva A, Matias-Guiu X, Krakstad C, Amant F, Gil-Moreno A, Colas E.

Int J Mol Sci. 2018 Aug 17;19(8). pii: E2431. doi: 10.3390/ijms19082431. Review.

Supplemental Content

Support Center